Physician profile
David J Sas
NPI 1922067776
$27,283.37
in general payments reported to CMS, 2019-2025
6 companies · $5,874 in 2025
The $5,874 reported for 2025 was more than what 89% of Pediatric Nephrology providers received nationally (typical 2025 total: $131).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,417 · 2020: $4,050 · 2021: $4,322 · 2022: $4,060 · 2023: $2,604 · 2024: $2,957 · 2025: $5,874.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Food and Beverage: $491 · Travel and Lodging: $182.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,761.25 |
| Food and Beverage | $490.96 |
| Travel and Lodging | $182.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $12,430.00 | 2020-2022 | |
| Novo Nordisk INC | $8,689.94 | 2023-2025 | Rivfloza |
| Travere Therapeutics, INC. | $3,418.91 | 2019-2021 | |
| Novo Nordisk Health Care Ag | $2,744.52 | 2024 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Sas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.